AlbaƱo, Crispina I.
HRN: 08-71-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/25/2025
11/30/2025
IV
2.25gms
Q6
Renal Dosing (Sepsis)
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes